MU, A., CS, J., JD, C., E, F., DJ, D., MM, D., . . . GA, P. (2026). Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? Annals of surgery, 284(2), 336. https://doi.org/10.1097/SLA.0000000000006609
Chicago Style (17th ed.) CitationMU, Ahmad, et al. "Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?" Annals of Surgery 284, no. 2 (2026): 336. https://doi.org/10.1097/SLA.0000000000006609.
MLA (9th ed.) CitationMU, Ahmad, et al. "Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?" Annals of Surgery, vol. 284, no. 2, 2026, p. 336, https://doi.org/10.1097/SLA.0000000000006609.